Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-263-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was not conducted according to a testing guideline or the GLP regulations. Furthermore, there was limited study detail upon witch to access the validity of the study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- GLP compliance:
- no
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Reaction mass of 2,2'-[methylenebis(4,1-phenyleneoxymethylene)]dioxirane and [2-({2-[4-(oxiran-2-ylmethoxy)benzyl]phenoxy}methyl)oxirane and [2,2'-[methylenebis(2,1-phenyleneoxymethylene)]dioxirane
- EC Number:
- 701-263-0
- Cas Number:
- 9003-36-5
- Molecular formula:
- C6 H6. C3 H5 Cl . C H2 O)x
- IUPAC Name:
- Reaction mass of 2,2'-[methylenebis(4,1-phenyleneoxymethylene)]dioxirane and [2-({2-[4-(oxiran-2-ylmethoxy)benzyl]phenoxy}methyl)oxirane and [2,2'-[methylenebis(2,1-phenyleneoxymethylene)]dioxirane
- Reference substance name:
- Formaldehyde, polymer with 2-(chloromethyl)oxirane and phenol
- IUPAC Name:
- Formaldehyde, polymer with 2-(chloromethyl)oxirane and phenol
- Reference substance name:
- Bisphenol F Diglycidylether (BPFDGE)
- IUPAC Name:
- Bisphenol F Diglycidylether (BPFDGE)
- Details on test material:
- As per IUCLID5 Sections 1.1 - 1.4.
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- hamster, Chinese
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Chinese hamsters weighing 22 - 31 grams were used for the study. They were maintained on a diet of NAFAG No. 924 and provided water ad libitum. The animal room had a temperature of 21 C +/- 1 C and a humidity of 70 - 80%. Illumination was 12 hr/day.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Polyethylene glycol
- Details on exposure:
- Oral gavage
- Duration of treatment / exposure:
- 2 days
- Frequency of treatment:
- Twice
- Post exposure period:
- none
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 1000, 2000, and 4000 mg/kg of body weight.
Basis:
nominal conc.
- No. of animals per sex per dose:
- 8
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide 64 mg/kg
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- the bone marrow cells wee harvested by centrifugation and the resulting cell pellets fixed in methanol/acetic acid 3:1 for 30 min at room temperature. The pellets were resuspended in fixative and centrifuged at 150 g for 5 minutes. The pellets were resuspended in fixative and stored overnight at 4 C. The pellets were resuspended again, centrifuged and the pellet resuspended in approximately 0.5 mL fixative. This final suspension was pipetted onto wet slides and stained with acetic-orcein.
- Evaluation criteria:
- No data
- Statistics:
- No data
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Treatment of chinese hamsters with the positive control cyclophosamide resulted a substantial increase in the number of bone marrow cells observed with chromosomal aberrations of approximately 24%. There was no increase of the chromosomal aberration frequency in bone marrow cells from the Chinese hamsters treated with Bisphenol F Diglycidylether (BPFDGE) up to the high dose level of 4000 mg/kg.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Oral gavage treatment of Chinese hamsters with Bisphenol F Diglycidylether up to a high dose of 4000 mg/kg did not cause an increase of structural chromosome damage in bone marrow cells. Therefore, BPFDGE is not genotoxic under the conditions of this in vivo assay. - Executive summary:
Bisphenol F Diglycidylether (BPFDGE) was accessed for the potential to induce chromosomal aberrations in the bone marrow cells of Chinese hamsters treated by oral gavage up to a high dose level of 4000 mg/kg. Oral gavage treatment of Chinese hamsters with Bisphenol F Diglycidylether up to a high dose of 4000 mg/kg did not cause an increase of structural chromosome damage in bone marrow cells. Therefore, BPFDGE is not genotoxic under the conditions of this in vivo assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.